| | 
Part, Chapter, Paragraph
1 II, 5. 1. 1| hyperphosphatemia, high plasma C Reactive Protein and Fibrinogen,
2 II, 5. 2. 6| progress and outcomes.~ ~Plasma cholesterol levels and CVD
3 II, 5. 2. 6| the average level of total plasma cholesterol in different
4 II, 5. 2. 6| graded association between plasma cholesterol levels and CHD
5 II, 5. 2. 6| association extends to values of plasma cholesterol well below those
6 II, 5. 2. 6| indicates that any reduction of plasma LDL cholesterol levels by
7 II, 5. 2. 6| association of stroke with plasma cholesterol levels is weak,
8 II, 5. 2. 6| interventions useful to control plasma cholesterol levels and the
9 II, 5. 2. 6| proper therapeutic target (plasma cholesterol levels ranging
10 II, 5. 2. 7| Non-pharmacological control of plasma cholesterol levels. Nutr
11 II, 5. 4. 1| random sample or a fasting plasma sample 7.0 mmol/l (126 mg/
12 II, 5. 4. 2| glucose, defined as a fasting plasma glucose equal or above 6.
13 II, 5. 4. 2| below 7.0 mmol/l (fasting plasma glucose 6,1 mmol/l and <
14 II, 5. 7. 4| hyperphosphatemia, high plasma C Reactive Protein and Fibrinogen,
15 III, 10. 2. 1| indicators – overweight, plasma homocysteine levels and
16 III, 10. 2. 2| 10.2.2. Plasma cholesterol levels.~ ~Observational
17 III, 10. 2. 2| the average level of total plasma cholesterol in different
18 III, 10. 2. 2| graded association between plasma cholesterol levels and CHD
19 III, 10. 2. 2| association extends to values of plasma cholesterol well below those
20 III, 10. 2. 2| mg/dL). A 10% increase in plasma total cholesterol is associated
21 III, 10. 2. 2| hand, a 10% reduction in plasma total cholesterol is followed
22 III, 10. 2. 2| recognised that any reduction of plasma LDL cholesterol levels by
23 III, 10. 2. 2| association of stroke with plasma cholesterol levels is weak,
24 III, 10. 2. 2| interventions useful to control plasma cholesterol levels as well
25 III, 10. 2. 2| proper therapeutic target (plasma cholesterol levels ranging
26 III, 10. 2. 5| otherwise combined with plasma albumin, due to a reduction
27 III, 10. 2. 5| albumin, due to a reduction of plasma levels of albumin;~- reduced
|
|
| |
